Dermavant Sciences

1 Follower


Dermavant Sciences is a specialty biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. They are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-i...


Add photos to showcase Dermavant Sciences’s culture


Add Dermavant Sciences’s values

Insider experiences

Share your experience of working at Dermavant Sciences

Todd Zavodnick
Chief Executive Officer
Philip M Brown
Chief Medical Officer
Chris Chapman
Chief Commercial Officer
David Rubenstein
Chief Scientific Officer
Chris Van Tuyl
General Counsel
Elaine Clark
VP, Global Regulatory Affairs, QA & PV
Anna Tallman
VP, Medical Affairs
Kara J. Stancell
VP, Investor Relations & Corporate Communications
Diana Villalobos
VP, Clinical
Peter Nicholson
SVP, Global Business Development
Paul Seaback
SVP, Technical Operations
Kristopher Garcia
VP, Accounting
Kenneth Peist
VP, Intellectual Property
Steve Piscitelli
VP, Clinical Pharmacology & Biometrics
Mark Luz
VP, Finance
Michael Swartzburg
Chief Financial Officer

Add your teams to show how people work together at Dermavant Sciences

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.